Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-31 Sale |
2024-07-31 9:40 pm |
ARYA Sciences Acquisition Corp IV | ARYD | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
499,000 | $0 | $0 | 2,647,500 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-27 Other |
2024-10-01 4:35 pm |
N/A N/A |
Adagio Medical Holdings Inc. | ADGM | ARYA Sciences Holdings IV Stone Adam Leo ALTMAN MICHAEL SETH 10% Owner |
3,501,600 | $0 | 3,501,600 (Direct) |
View |
Ownership |
2024-08-01 5:16 pm |
N/A N/A |
Adagio Medical Holdings Inc. | ADGM | ARYA Sciences Holdings IV Stone Adam Leo ALTMAN MICHAEL SETH 10% Owner |
0 | $0 | 3,501,600 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-17 6:03 pm |
N/A 2034-06-14 |
Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-13 4:37 pm |
N/A N/A |
Perceptive Capital Solutions Corp | PCSC | ALTMAN MICHAEL SETH Chief Business Officer 10% Owner |
286,250 | $10 | 286,250 (Indirect) |
View |
Ownership |
2024-06-11 5:58 pm |
N/A N/A |
Perceptive Capital Solutions Corp | PCSC | ALTMAN MICHAEL SETH Chief Business Officer |
0 | $0 | 2,066,250 (Indirect) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:49 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 8:52 pm |
N/A 2033-06-15 |
Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:43 pm |
N/A 2032-06-15 |
Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director |
86,467 | $0 | 86,467 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-15 5:53 pm |
N/A N/A |
ARYA Sciences Acquisition Corp V | ARYE | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
499,000 | $10 | 499,000 (Indirect) |
View |
Ownership |
2021-07-12 8:07 pm |
N/A N/A |
ARYA Sciences Acquisition Corp V | ARYE | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
0 | $0 | 3,617,500 (Indirect) |
View |
| 2021-06-09 Conversion |
2021-06-11 5:32 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director |
4,146,500 | $0 | 543,435 (Indirect) |
View |
| 2021-06-09 Option Award |
2021-06-11 5:32 pm |
2021-06-09 2031-06-09 |
Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director |
44,435 | $0 | 543,435 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:28 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-02 4:30 pm |
N/A N/A |
ARYA Sciences Acquisition Corp IV | ARYD | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
499,000 | $10 | 499,000 (Indirect) |
View |
Ownership |
2021-02-25 8:32 pm |
N/A N/A |
ARYA Sciences Acquisition Corp IV | ARYD | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
0 | $0 | 3,647,500 (Indirect) |
View |
| 2020-08-11 Other |
2020-08-11 8:38 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
499,000 | $10 | 998,000 (Indirect) |
View |
Ownership |
2020-08-06 9:47 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
0 | $0 | 3,647,500 (Indirect) |
View |
| 2020-06-09 Other |
2020-06-09 8:23 pm |
N/A N/A |
ARYA Sciences Acquisition Corp II | ARYB | ALTMAN MICHAEL SETH Chief Financial Officer |
499,000 | $10 | 998,000 (Indirect) |
View |
Ownership |
2020-06-04 9:46 pm |
N/A N/A |
ARYA Sciences Acquisition Corp II | ARYB | ALTMAN MICHAEL SETH Chief Financial Officer |
0 | $0 | 3,647,500 (Indirect) |
View |
| 2020-04-30 Option Award |
2020-05-01 6:44 pm |
N/A 2030-04-29 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
14,500 | $0 | 14,500 (Direct) |
View |